Intergado™ System and steer drinking water. by M. Jordana Rivero (14610947)

Subjects:

Change in drinking behaviour over time: water intake per visit. by M. Jordana Rivero (14610947)

Subjects:

Feeds composition and nutritional value of the diet fed to Nellore steers with and without access to shade finished in feedlot during spring in a tropical environment. by M. Jordana Rivero (14610947)

Subjects:

Structure used to provide shade. by M. Jordana Rivero (14610947)

Subjects:

Clinical diagnosis and abnormal signals of AEFIs(/10,000). by Chao Zhang (51048)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Flow of selecting the study participants. by Kazuhiro Suzuki (160528)

Subjects:

P–P and Q–Q plots for assessing normality of residuals. by Kazuhiro Suzuki (160528)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Changes in reported rate of AEFIs in the pre-LAW and post-LAW period(/10000). by Chao Zhang (51048)

Subjects:

Data. by Chao Zhang (51048)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Comparing admission rate of each ward before and during COVID-19 outbreak. by Mahsa Motiei (18275525)

Subjects:

Comparing diagnosis based on ICD-10 criteria in patients before and after COVID-19 outbreak. by Mahsa Motiei (18275525)

Subjects:

Demographic information of participating emergency medicine physicians. by Leigh V. Evans (19753987)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

CONSORT flow diagram depicting participant flow through the trial. by Leigh V. Evans (19753987)

Subjects:

Characteristics of the participants. by Kazuhiro Suzuki (160528)

Subjects: